SOURCE: Impact Fusion International, Inc.

Impact Fusion International, Inc.

January 25, 2010 09:55 ET

Impact Fusion International, Inc. Places Significant Order to Meet Increased Demand for Intact Digest™

Demand Exceeding Supply

MARGATE, FL--(Marketwire - January 25, 2010) - Impact Fusion International, Inc. (PINKSHEETS: IFUS) announced the demand for the first product launch of Intact Digest™ with the Company's proprietary blend of Nutri-Mastic™ has exceeded inventory on hand and is in backorder status. New customer orders and reorders from existing customers generated through our established distribution network and via internet sales in our ecommerce website, demand has exceeded supply.

"We have reassessed our inventory levels and a significant order has been placed to reflect the success of the product," said CEO Marc Walther. "I am pleased with the response of Intact Digest™ even before we commence the full implementation of our marketing campaign, scheduled for February 2010." Over the two weeks most of our product line, which can be found on our website, will start to show "in-stock" status.

Intact Digest™ with Nutri-Mastic™ gives you the right amounts of essential nutrients to support a healthy digestive system. The comprehensive benefits from Intact Digest™ assists with overall occasional constipation, relieves occasional heartburn, supports dairy digestion, supports healthy hair, skin, nails and is all natural. Nutri-Mastic™ is a patent pending proprietary formula, containing clinically researched ingredients know to benefit those suffering from Crohn's Disease, IBS, Ulcerated Colitis, Diabetes, Hypertension, H Pylori, Colon Cancer, Prostrate Cancer and Leukemia. Clinical trials to support these uses are limited.

Read More:

Other Intact Nutrition™ Products:

VOD Newswire Video Format:

About Impact Fusion International, Inc.:

Impact Fusion International, Inc. is in the business of marketing products in the "Health and Wellness" sector of all international markets. It is the company's mission to invent, develop and market these proprietary products worldwide for the health and well being of humans and animals.

This release may include projections of future results and "forward-looking statements" as that term is defined in Section 27A of the Securities Act of 1933 as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934 as amended (the "Exchange Act"). All statements that are included in this release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in these forward-looking statements are reasonable; it can give no assurances that such expectations will prove to have been correct. Important factors that could cause actual results to differ materially from the expectations disclosed in this release, including, without limitation, in conjunction with those forward-looking statements contained in this release.

Contact Information